EUROIMMUN Logo
Find
X
Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Press release, March 3rd 2025

Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection ...

SARS-CoV-2 vaccine safety in an autoimmunity-prone population

A new study has shown that mRNA vaccines against SARS-CoV-2 do not induce short-term worsening of autoimmunity in patients with autoimmune liver diseases (AILD). The collaborative study between ...

Raising Awareness for Encephalitis: A Personal Story

Encephalitis is a condition that many people know little about, yet its impact can be life-changing for those affected and their families. We sat down with our National Sales Manager, Rhys Thorne, to ...

Exploring IIFT Microscopy: A Look at the EUROStar IV Plus

Microscopy has come a long way and in the world of indirect immunofluorescence testing (IIFT), advancements in technology continue to make life easier for laboratory professionals. If you’ve ever ...

Serum uromodulin may indicate acute kidney injury in COVID-19 patients

Serum uromodulin (sUmod) represents a promising biomarker for acute kidney injury (AKI) in COVID-19 patients, as reported in a published collaborative study between EUROIMMUN, St Georg Hospital ...

Another piece of the puzzle in rheumatological diagnostics

Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic ...

Two companies, one goal

Panadea and EUROIMMUN are two companies with one common important goal: The development, production and distribution of test systems for the detection of the pathogens causing such emerging diseases, ...

Well prepared for the flu season: diagnostics in the interest of public health

Well prepared for the flu season: diagnostics in the interest of public health

At regular intervals, sometimes daily, the latest influenza figures are published. National health authorities around ...

The new potential gold standard for myasthenia gravis autoantibody diagnostics

Myasthenia gravis (MG) is an autoimmune-mediated myasthenic disorder with the main symptom of exertion-related muscle weakness. The disease results from functional loss of the nicotinic acetylcholine ...

Novel autoantibody associated with Hodgkin’s lymphoma

Autoantibodies targeting the protein RGS8 (regulator of G-protein signaling 8) are associated with a particular subtype of Hodgkin’s lymphoma, as described in a recently published study performed in a ...

Page 1 of 12.

Back to top